PUBLICATIONS

1. Awadallah, N., Pino, J. A., Koutzoumis, D. N., & Torres, G. E. (2023). Characterizing Dopamine Transporter Mediated Uptake and Efflux in Brain Slices: A New Approach. Dopaminergic System Function and Dysfunction: Experimental Approaches, 83-99.

​

2. Stokes, C., Pino, J. A., Hagan, D. W., Torres, G. E., Phelps, E. A., Horenstein, N. A., & Papke, R. L. (2022). Betel quid: New insights into an ancient addiction. Addiction Biology, 27(5), e13223.

​

3. Pino JA, Awadallah N, Norris AM, Torres GE. (2021). A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices.
J Vis Exp. 2021 Aug 11;(174). doi: 10.3791/62127. PMID: 34459801

 

4. Pino JA, Nuñez-Vivanco G, Hidalgo G, Reyes Parada M, Khoshbouei H, Torres GE. (2021). Identification of Critical Residues in the Carboxy Terminus of the Dopamine Transporter Involved in the G Protein βγ-Induced Dopamine Efflux.
Front Pharmacol. 2021 Mar 24;12:642881. doi: 10.3389/fphar.2021.642881. eCollection 2021. PMID: 33841159

​

5.  I. P. Alonso, J. A. Pino, S. Kortagere, G. E. Torres and R. A. España (2021). Dopamine transporter function fluctuates across sleep/wake state: potential impact for addiction.

Neuropsychopharmacology. 2021 Mar;46(4):699-708. doi: 10.1038/s41386-020-00879-2. Epub 2020 Oct 8. PMID: 33032296

 

6. Koutzoumis DN, Vergara M, Pino J, Buddendorff J, Khoshbouei H, Mandel RJ, Torres GE. (2020). Alterations of the Gut Microbiota with Antibiotics Protects Dopamine Neuron Loss and Improve Motor Deficits in a Pharmacological Rodent Model of Parkinson's disease. 

Exp Neurol. 2020 Mar;325:113159. doi: 10.1016/j.expneurol.2019.113159. Epub 2019 Dec 13. PMID: 31843492

​

7. Lebowitz JJ, Pino JA, Mackie PM, Lin M, Hurst C, Divita K, Collins AT, Koutzoumis DN, Torres GE, Khoshbouei H. (2019). Kv2.1 clusters regulate dopamine transporter trafficking and function.

J Biol Chem. 2019 Apr 26;294(17):6957-6971. doi: 10.1074/jbc.RA119.007441. Epub 2019 Mar 1. PMID: 30824538

​

8. Mauna JC, Harris SS, Pino JA, Edwards CM, DeChellis-Marks MR, Bassi CD, Garcia-Olivares J, Amara SG, Guajardo F, Sotomayor-Zarate R, Terminel M, Castañeda M, Vergara M, Baust T, Thiels E, Torres GE. (2019). G protein βγ subunits Play a Critical Role in the Actions of Amphetamine.

Transl Psychiatry. 2019 Feb 11;9(1):81. doi: 10.1038/s41398-019-0387-8. PMID: 30745563

​

9. Colon-Perez LM, Pino JA, Saha K, Pompilus M, Kaplitz S, Choudhury N, Jagnarine DA, Geste JR, Levin BA, Wilks IJ, Setlow B, Bruijnzeel AW, Khoshbouei H, Torres GE, Febo M. (2018). Functional connectivity, behavioral and dopaminergic alterations 24 hours following acute exposure to synthetic bath salt drug methylenedioxypyrovalerone.

Neuropharmacology. 2018 Jul 15;137:178-193. doi: 10.1016/j.neuropharm.2018.04.031. Epub 2018 May 3. PMID: 29729891

​

10. Parra LA, Baust TB, Smith AD, Jaumotte JD, Zigmond MJ, Torres S, Leak RK, Pino JA, Torres GE (2016) The Molecular Chaperone Hsc70 Interacts with Tyrosine Hydroxylase to Regulate Enzyme Activity and Synaptic Vesicle Localization.  

J Biol Chem. 2016 Aug 19;291(34):17510-22. doi: 10.1074/jbc.M116.728782. Epub 2016 Jun 30. PMID: 27365397

​

11. Reddy IA*, Pino JA*, Weikop P, Osses N, Sørensen G, Bering T, Valle C, Bluett RJ, Erreger K, Wortwein G, Reyes JG, Graham D, Stanwood GD, Hackett TA, Patel S, Fink-Jensen A, Torres GE, Galli A. (2016). Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels.

Transl Psychiatry. 2016 May 17;6(5):e809. doi: 10.1038/tp.2016.86. PMID: 27187231

​